Robustness of Catalytically Dead Cas9 Activators in Human Pluripotent and Mesenchymal Stem Cells. (2020)
Attributed to:
An inducible CRISPR/dCAS9 strategy for directed differentiation of pluripotent stem cells
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.omtn.2020.02.009
PubMed Identifier: 32171171
Publication URI: http://europepmc.org/abstract/MED/32171171
Type: Journal Article/Review
Volume: 20
Parent Publication: Molecular therapy. Nucleic acids
ISSN: 2162-2531